blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2667851

EP2667851 - TESTOSTERONE FORMULATIONS [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  03.12.2021
Database last updated on 03.04.2025
FormerThe patent has been granted
Status updated on  12.11.2018
Most recent event   Tooltip03.12.2021Opposition rejectedpublished on 05.01.2022  [2022/01]
Applicant(s)For all designated states
Ferring BV
Polaris Avenue 144
2132 JX Hoofddorp / NL
[2013/49]
Inventor(s)01 / GRENIER, Arnaud
6 rue des Bergers
F-68440 Steinbrunn le Haut / FR
02 / CARRARA, Dario, N.
Storchenweg 3
CH-4104 Oberwil / CH
 [2013/49]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2016/20]
Former [2013/49]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date12700406.718.01.2012
[2016/20]
WO2012EP50695
Priority number, dateEP2011015221026.01.2011         Original published format: EP 11152210
US201161436207P26.01.2011         Original published format: US 201161436207 P
[2013/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012101016
Date:02.08.2012
Language:EN
[2012/31]
Type: A1 Application with search report 
No.:EP2667851
Date:04.12.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 02.08.2012 takes the place of the publication of the European patent application.
[2013/49]
Type: B1 Patent specification 
No.:EP2667851
Date:18.05.2016
Language:EN
[2016/20]
Search report(s)International search report - published on:EP02.08.2012
ClassificationIPC:A61K9/06, A61K47/10, A61P5/26, A61K31/568, A61K31/58, A61K9/00
[2013/49]
CPC:
A61K31/568 (EP,KR,RU,US); A61K9/06 (KR,RU); A61K31/58 (EP,RU,US);
A61K47/10 (EP,KR,RU,US); A61K47/18 (US); A61K47/32 (RU,US);
A61K9/0014 (EP,RU,US); A61K9/10 (KR); A61K9/107 (KR);
A61K9/70 (RU); A61P15/00 (EP); A61P15/08 (EP);
A61P15/10 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P25/24 (EP); A61P3/02 (EP); A61P5/00 (EP);
A61P5/26 (EP); A61P5/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/49]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:TESTOSTERONFORMULIERUNGEN[2013/49]
English:TESTOSTERONE FORMULATIONS[2013/49]
French:FORMULATIONS DE TESTOSTÉRONE[2013/49]
Entry into regional phase26.07.2013National basic fee paid 
26.07.2013Designation fee(s) paid 
26.07.2013Examination fee paid 
Examination procedure26.07.2013Examination requested  [2013/49]
23.12.2013Amendment by applicant (claims and/or description)
02.03.2015Despatch of a communication from the examining division (Time limit: M04)
19.03.2015Reply to a communication from the examining division
23.07.2015Despatch of a communication from the examining division (Time limit: M02)
27.07.2015Reply to a communication from the examining division
02.12.2015Communication of intention to grant the patent
23.03.2016Fee for grant paid
23.03.2016Fee for publishing/printing paid
23.03.2016Receipt of the translation of the claim(s)
Divisional application(s)EP16169138.1  / EP3072505
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.03.2015
Opposition(s)Opponent(s)01  17.02.2017  23.02.2017  ADMISSIBLE
Müller Fottner Steinecke Rechtsanwalts- und Patentanwaltspartnerschaft mbB
P.O. Box 11 40
Römerstrasse 16b
52428 Jülich / DE
Opponent's representative
Witthoff Jaekel Steinecke Patentanwälte PartG mbB, et al, et al
Postfach 1140
52412 Jülich / DE
 [2020/19]
Former [2017/13]
Opponent(s)01  17.02.2017  23.02.2017  ADMISSIBLE
Müller Fottner Steinecke Rechtsanwalts- und Patentanwaltspartnerschaft mbB
P.O. Box 11 40
Römerstrasse 16b
52428 Jülich / DE
Opponent's representative
Steinecke, Peter, et al, et al
Müller Fottner Steinecke
Rechtsanwalts- und Patentanwaltspartnerschaft mbB
P.O. Box 1140
52412 Jülich / DE
20.04.2017Invitation to proprietor to file observations on the notice of opposition
30.10.2017Reply of patent proprietor to notice(s) of opposition
10.10.2018Date of oral proceedings
13.11.2018Despatch of minutes of oral proceedings
13.11.2018Date of despatch of rejection of opposition
26.11.2021Legal effect of rejection of opposition [2022/01]
Appeal following opposition22.01.2019Appeal received No.  T0280/19
22.03.2019Statement of grounds filed
16.11.2021Result of appeal procedure: appeal of the opponent was rejected
19.11.2021Despatch of the decision of the Board of Appeal
Fees paidRenewal fee
21.01.2014Renewal fee patent year 03
13.01.2015Renewal fee patent year 04
11.01.2016Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY18.05.2016
MC18.05.2016
MK18.05.2016
SM18.05.2016
MT18.01.2017
[2019/51]
Former [2019/46]CY18.05.2016
MC18.05.2016
SM18.05.2016
MT18.01.2017
Former [2018/43]MC18.05.2016
SM18.05.2016
MT18.01.2017
Former [2017/47]MC18.05.2016
SM18.05.2016
Former [2017/13]SM18.05.2016
Cited inInternational search[XAI]WO2004080413  (ANTARES PHARMA IPL AG [CH], et al)
by applicantUS7198801
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.